Product Images Temozolomide

This is a medication for oral administration consisting of capsules containing 100mg of temozolomide. The usual dosage directions can be found in the package insert. It is stored at room temperature and protected from light. The medication is considered cytotoxic and the accompanying directions should be followed carefully. It is manufactured by Deva Holding AS in Istanbul, Turkey and distributed by Ascend Laboratories LLC in Parsippany, NJ.*

This is a description for a medication called "Temozolomide Capsules, USP". The medication is manufactured in Istanbul, Turkey by Deva Holding A5 and distributed by Ascend Laboratories in Parsippany, NJ. Each capsule contains 140 mg of temozolomide and is for oral consumption only. The recommended storage temperature is 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The medication should be stored in light-resistant containers as defined in USP/NF. It is a cytotoxic medication and the usual dosage should be determined by a healthcare professional. More detailed directions are available in the package insert that accompanies the medication.*

This appears to be a medication label for Temozolomide capsules, which are used for oral administration. Each capsule contains 180 mg of the medication, and the recommended daily dosage should be established through careful consideration of the package insert. The medication is distributed by Ascend Laboratories and should be stored at a temperature between 15-30°C. The label also mentions the packaging containing 5 capsules, and a lot number (WOCETT50147) is included.*

This is a description for a medication named Temozolomide, which comes in 20 mg capsules. The medication is intended to be dispensed in tightly light-resistant containers as defined in USP/N. The usual dosage is specified in the package insert. The medication is manufactured and distributed by Ascend Laboratories. It is recommended to carefully follow the directions when taking the medication for establishing a daily regimen. The package contains 5 capsules to be stored at controlled room temperature between 15°-30°C (59°-86°F).*

This is a description of a medication called Temozolomide Capsules, USP that are used for oral administration. Each capsule contains 250 mg of the medication and is intended for daily use. The medication comes in tight, light-resistant containers and should be stored at room temperature. The accompanying package insert should be consulted for dosage recommendations. The medication is manufactured in Istanbul and distributed by Ascend Laboratories in New Jersey.*

This is a medication called Temozolomide, which is usually administered orally through capsules of varying strengths to establish a daily regimen. Each capsule contains 5 mg of temozolomide and comes in a tight, light-resistant container defined by the USP/N. The recommended dosage can be found in the package insert and it is advised to read the directions carefully before use. The medication is distributed by Ascend Laboratories and should be stored at room temperature.*

This is a summary of survival data for the ITT population. The hazard ratio for overall survival is 0.63 with a 95% confidence interval from 0.52 to 0.75. The log-rank p-value is less than 0.0001. The time from randomization is measured in months from 12 to 28.*